Brazil's CADE probes drugmaker for price hike
Brazil’s public prosecutor has complained against Gilead Sciences to the country’s competition enforcer, CADE, reportedly about the drugmaker raising the price of a hepatitis C medication by more than 1400%.
To read more
Subscribe to Latin Lawyer
Subscribe and start reading now
Latin Lawyer is your definitive source of news, analysis, and research from the Latin American legal community. It keeps you up to speed with the issues and trends that matter and provides the data and tools you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10